Cosméticos com presença de disruptores endócrinos e gestação: percepção de risco pelos profissionais de saúde

Laís dos Santos Rocha Souza; Ana Izabel de Oliveira Neta; Júlia Souza Gomes; Érika Andrade e Silva; Suellen Cristina Dias Emidio; Alanna Fernandes Paraiso

doi:10.15253/2175-6783.20242593619

Authors

Laís dos Santos Rocha Souza Universidade Federal de Juiz de Fora https://orcid.org/0009-0005-7481-5856
Ana Izabel de Oliveira Neta Universidade Federal de Juiz de Fora https://orcid.org/0000-0003-3777-1290
Júlia Souza Gomes Universidade Federal de Juiz de Fora https://orcid.org/0009-0000-8390-8935
Érika Andrade e Silva Universidade Federal de Juiz de Fora https://orcid.org/0000-0002-5752-7829
Suellen Cristina Dias Emidio Universidade Federal de Juiz de Fora https://orcid.org/0000-0003-2790-0271
Alanna Fernandes Paraiso Universidade Federal de Juiz de Fora https://orcid.org/0000-0001-7400-140X

DOI:

https://doi.org/10.15253/2175-6783.20242593619

Keywords:

Pregnancy; Cosmetics; Endocrine Disruptors; Health Personnel.

Abstract

Objective: to understand the perception of Primary Health Care health professionals regarding the risks associated with the use of cosmetics containing endocrine disruptors during pregnancy. Methods: this was a qualitative study. The participants were 17 health professionals who visited pregnant women in Primary Health Care. Data was collected through semi-structured interviews. The interviews were analyzed using Content Analysis and theoretical references from researchers in the field. Results: the majority of participants had little knowledge of the concept of endocrine disruptors, reported little confidence in recommending or not recommending the use of cosmetics and personal hygiene products, and also showed little knowledge of the risks they may pose to health. Conclusion: Health professionals have shown that their knowledge of the risks of endocrine disruptors present in cosmetics is fragile and, consequently, they find it difficult to guide pregnant women to reduce harmful exposure. Contributions to practice: raising awareness among professionals of the need for constant updating to provide safe advice to pregnant women.

References

Gómez-Roig MD, Pascal R, Cahuana MJ, García-Algar O, Sebastiani G, Andreu-Fernández V, et al. Environmental exposure during pregnancy: influence on prenatal development and early life: a comprehensive review. Fetal Diagn Ther. 2021;48(4):245-57. doi: https://doi.org/10.1159/000514884

Tabares GG, Mordecay VC. Disruptores endócrinos em reproducción. Rev Colomb Menopausa [Internet]. 2020 [cited Apr 23, 2024];26(1):7-19. Available from: https://docs.bvsalud.org/biblioref/2021/05/1224400/disruptores-endocrinos.pdf

Puche-Juarez M, Toledano JM, Moreno-Fernandez J, Gálvez-Ontiveros Y, Rivas A, Diaz-Castro J, et al. The role of endocrine disrupting chemicals in gestation and pregnancy outcomes. Nutrients. 2023;15(21):4657. doi: https://doi.org/10.3390/nu15214657

Li H, Zheng J, Wang H, Huang G, Huang Q, Feng N, et al. Maternal cosmetics use during pregnancy and risks of adverse outcomes: a prospective cohort study. Sci Rep. 2019;9(1):8030. https://doi.org/10.1038/s41598-019-44546-z

Green MP, Harvey AJ, Finger BJ, Tarulli GA. Endocrine disrupting chemicals: Impacts on human fertility and fecundity during the peri-conception period. Environ Res. 2021;194:110694. doi: https://doi.org/10.1016/j.envres.2020.110694

Pinheiro AC, Queirós C, Alvim AS. Manifestações dermatológicas na gravidez. Acta Med Port. 2022; 35(5):376-83. doi: https://dx.doi.org/10.20344/amp.13520

Philippat C, Rolland M, Lyon-Caen S, Pin I, Sakhi AK, Sabaredzovic A, et al. Pre- and early post-natal exposure to phthalates and DINCH in a new type of mother-child cohort relying on within-subject pools of repeated urine samples. Environ Pollut. 2021;287:117650. doi: http://dx.doi.org/10.1016/j.envpol.2021.117650

Marguillier E, Beranger R, Garlantezec R, Levêque J, Lassel L, Rousseau C, et al. Endocrine disruptors and pregnancy: Knowledge, attitudes and practice of perinatal health professionals. A French multicentre survey. Eur J Obstet Gynecol Reprod Biol. 2020;252:233-8. doi: https://doi.org/10.1016/j.ejogrb.2020.06.032

Albouy M, Parthenay M, Nogues M, Leyris A, Degorce L, Barthelemy Z, et al. A clinical preventive strategy based on a digital tool to improve access to endocrine disruptors exposure prevention: the MEDPREVED study. Int J Environ Res Public Health. 2022;19(19):11993. doi: https://doi.org/10.3390/ijerph191911993

Ouazzani HE, Rouillon S, Venisse N, Sifer-Rivière L, Dupuis A, Cambien G, et al. Impact of perinatal environmental health education intervention on exposure to endocrine disruptors during pregnancy — PREVED study: study protocol for a randomized controlled trial. Trials. 2021; 22(1):876. doi: https://doi.org/10.1186/s13063-021-05813-5

Park S, Chung C. How do mothers with young children perceive endocrine-disrupting chemicals?: an exploratory qualitative study. Korean J Women Health Nurs. 2023;29(4):337-47. doi: https://dx.doi.org/10.4069/kjwhn.2023.11.28

Ministério da Saúde (BR). e-Gestor Atenção Básica. Informação e Gestão da Atenção Básica [Internet]. 2020 [cited July 13, 2024]. Available from: https://egestorab.saude.gov.br/paginas/acessoPublico/relatorios/relHistoricoCoberturaAB.xhtml

Bardin L. Análise de conteúdo. São Paulo: Edições 70; 2016.

Marie C, Garlantézec R, Béranger R, Ficheux AS. Use of cosmetic products in pregnant and breastfeeding women and young children: Guidelines for interventions during the perinatal period from the French National College of Midwives. J Midwifery Womens Health. 2022;67(Suppl 1):99-112. doi: https://dx.doi.org/10.1111/jmwh.13428

Yang Z, Zhang J, Wang M, Wang X, Liu H, Zhang F, et al. Prenatal endocrine-disrupting chemicals exposure and impact on offspring neurodevelopment: a systematic review and meta-analysis. Neurotoxicology. 2024;103:335-57. doi: https://doi.org/10.1016/j.neuro.2024.07.006

Kirtana A, Seetharaman B. Comprehending the role of endocrine disruptors in inducing epigenetic toxicity. Endocr Metab Immune Disord Drug Targets. 2022;22(11):1059-72. https://doi.org/10.2174/1871530322666220411082656

Predieri B, Iughetti L, Bernasconi S, Street ME. Endocrine disrupting chemicals’ effects in children: what we know and what we need to learn? Int J Mol Sci. 2022;23(19):11899. doi: https://doi.org/10.3390/ijms231911899

Kiess W, Häussler G, Vogel M. Endocrine-disrupting chemicals and child health. Best Pract Res Clin Endocrinol Metab. 2021;35(5):101516. doi: https://doi.org/10.1016/j.beem.2021.101516

Derakhshan A, Shu H, Broeren MAC, Kortenkamp A, Lindh CH, Demeneix B, et al. Association of endocrine disrupting chemicals exposure with human chorionic gonadotropin concentrations in pregnancy. Environ Int. 2023;178:108091. doi: https://doi.org/10.1016/j.envint.2023.108091

Preston EV, Fruh V, Quinn MR, Hacker MR, Wylie BJ, O’Brien K, et al. Endocrine disrupting chemical-associated hair product use during pregnancy and gestational age at delivery: a pilot study. Environ Health. 2021;20(1):86. doi: https://doi.org/10.1186/s12940-021-00772-5

Liu B, Zhu X, Zhang Y, Yan J, Ren A, Su Y, et al. Influence of maternal endocrine disrupting chemicals exposure on adverse pregnancy outcomes: a systematic review and meta-analysis. Ecotoxicol Environ Saf. 2024;270:115851. doi: https://dx.doi.org/10.1016/j.ecoenv.2023.115851

Gore AC, Crews D, Doan LL, Merril ML, Patisaul H, Zota A. Introdução aos disruptores endócrinos (DEs) um guia para governos e organizações de interesse público [Internet]. 2014 [cited Apr 13, 2024]. Available from: https://www.endocrino.org.br/media/uploads/PDFs/ipen-intro-edc-v1_9h-pt-print.pdf

Rolfo A, Nuzzo AM, Amicis R, Moretti L, Bertoli S, Leone A. Fetal-maternal exposure to endocrine disruptors: correlation with diet intake and pregnancy outcomes. Nutrients. 2020;12(6):1744. doi: https://doi.org/10.3390/nu12061744

Asori M, Omololu F, Ande A, Babatunde E, Adewale O, Akande O. Impacts of endocrine disruptors on reproductive health in the era of increased personal care and beauty products usage. Bull Natl Res Cent. 2022;46(1):61. doi: https://dx.doi.org/10.1186/s42269-022-00826-w

Marinello WP, Patisaul HB. Endocrine disrupting chemicals (EDCs) and placental function: impact on fetal brain development. Adv Pharmacol. 2021;92:347-400. doi: https://doi.org/10.1016/bs.apha.2021.04.003

Lin HW, Feng HX, Chen L, Yuan XJ, Tan Z. Maternal exposure to environmental endocrine disruptors during pregnancy is associated with pediatric germ cell tumors. Nagoya J Med Sci. 2020;82(2):323-33. doi: https://doi.org/10.18999/nagjms.82.2.315

Arruda HFBR, Silva LS. Esthetic skin care with the use of dermocosmetics and cosmetics during pregnancy. Braz J Develop. 2022;8(12):77348-69. doi: https://dx.doi.org/10.34117/bjdv8n12-040

Gomes FS, Paula TAP, Souza VP, Araújo CM, Ferreira BES. Os impactos dos desreguladores endócrinos sobre a puberdade precoce: revisão integrativa. Rev Eletr Evid Enferm. 2021;7(1):12-25. doi: http://dx.doi.org/10.26544/Reeev7n12021-12-25

Haggerty DK, Upson K, Pacyga DC, Franko JE, Braun JM, Strakovsky RS. Reproductive toxicology: pregnancy exposure to endocrine disrupting chemicals: implications for women’s health. Reproduction. 2021;162(5):169-80. doi: http://dx.doi.org/10.1530/REP-21-0051

Banker M, Puttabyatappa M, O’Day P, Goodrich JM, Kelley AS, Domino SE, et al. Association of maternal-neonatal steroids with early pregnancy endocrine disrupting chemicals and pregnancy outcomes. J Clin Endocrinol Metab. 2021;106(3):665-87. doi: https://doi.org/10.1210/clinem/dgaa909